Persephone Biosciences Company

Persephone Biosciences uses artificial intelligence to rapidly develop microbial based immunotherapies to enable a lifetime without cancer.
Technology: COVID
Industry: AI, Artificial Intelligence, Biotechnology, Early Drug Development, Health Care, Medical, Preclinical development, Preventive Tech, United States
Headquarters: San Diego, California, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 8
Total Funding: 15120000
Estimated Revenue: Less than $1M
Last Funding Date: 2022-07-19
Last Funding Type: Seed

Visit Website
Register and Claim Ownership